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Multiplex PCR assays for the detection and identification of various Streptococcus suis strains in tonsillar
specimens from pigs were developed and evaluated. In two separate reactions, five distinct DNA targets were
amplified. Three targets, based on the S. suis capsular polysaccharide (cps) genes specific for serotypes 1 (and
14), 7, and 9, were amplified in multiplex PCR I. Two other targets, based on the serotype 2- (and 1/2-) specific
cps gene and the epf gene, encoding the EF proteins of virulent serotype 2 and highly virulent serotype 1 strains,
were amplified in multiplex PCR II. To identify false-negative results, firefly luciferase (luc) DNA and primers
based on the luc gene were included in the assay. The multiplex PCR assays were evaluated with tonsillar
specimens from pigs infected with S. suis strains. The results obtained with the PCR assays were compared with
the results obtained with a bacteriological examination. Most (94%) of the results obtained with multiplex PCR
assays were confirmed by the bacteriological examination. The PCR method seems to be more sensitive
compared to the bacteriological method, since the remaining 6% of the samples were positive by PCR and
negative by bacteriological examination. These results indicate that the PCR method is highly specific for the
detection of S. suis strains most frequently involved in clinical disease in infected pig herds. The serotypes
found by PCR in tonsillar specimens from diseased pigs were compared with the serotypes of the strains
isolated from the affected tissues of the same pigs. The results showed that there is significant association
between carriership and clinical illness for S. suis serotype 9 and EF-positive serotype 2 strains and not for
serotype 7 and EF-negative serotype 2 (or 1/2) strains.
Streptococcus suis is an important agent of meningitis, ar-
thritis, pericarditis, peritonitis, pneumonia, and sudden death
in young piglets. Most infections occur when pigs are at the age
of 3 to 12 weeks. Especially after weaning, the pigs are suscep-
tible to infection (11). The disease has a worldwide distribution
and causes considerable losses to pig production (3). Attempts
to control the disease are still hampered by the lack of effective
vaccines and sensitive diagnostic tools.
So far, 35 serotypes of S. suis based on capsular antigens
have been described (5, 6, 8, 14), with serotypes 1/2, 1, 2, 7, 9,
and 14 being among the most prevalent serotypes recovered
from diseased animals (29). S. suis colonizes the palatine ton-
sils of both healthy and diseased pigs (2, 12, 25). Subclinical
carrier pigs are known to be the source of infection for young
sensitive pigs (9). Detection of these carriers may lead to a
better understanding of the epidemiology of S. suis infections
and may help in the development of effective control measures.
At present, no sensitive and specific methods are available for
the detection of pigs carrying S. suis strains. The bacteria can
be cultured from tonsillar specimens by traditional microbio-
logical techniques. However, tonsils are also colonized by non-
virulent S. suis strains and other streptococcal species, which
are difficult to distinguish on the basis of colony morphology.
To meet this shortage, serotype-specific isolation techniques
with selective-elective media (25) and an immunomagnetic
separation technique (7) have been developed. However, so far
their use has been limited to serotype 2 and 1/2 strains. More-
over, these methods are very laborious and time-consuming
and have a low sensitivity.
For more convenient detection of specific serotypes and
virulence-associated phenotypes of S. suis, PCR procedures
could be used. Recently, a PCR assay was described and
successfully applied to detect virulent S. suis serotype 2 and
highly virulent serotype 1 strains and weakly virulent S. suis
serotype 2 strains in tonsillar specimens from pigs (28). The
PCR primers in this assay are based on the sequence of the
extracellular protein factor (epf) gene encoding the EF pro-
tein, a marker of virulence in serotype 2 strains and highly
virulent serotype 1 strains (23, 27). The PCR primers also
amplified fragments of the related epf* gene, encoding the
EF* protein of weakly virulent serotype 2 strains. (The epf
and epf* genes are highly homologous; however, the epf*
genes contain several repeated inserts [20] and thus encode
proteins with higher molecular weights [asterisks are used
herein to distinguish both the variant genes and the proteins
they encode]. Therefore, EF*-producing strains gave rise to
larger PCR products than the virulent EF-positive strains of
S. suis serotype 1 and 2 [28]).
In addition, we recently developed PCR assays for detec-
tion of S. suis serotype 1 (and 14), 2 (and 1/2), 7, and 9
strains in tonsillar specimens from pigs (21, 22). These as-
says are based on the capsular polysaccharide (cps) biosyn-
thesis loci of S. suis serotypes 1, 2, 7, and 9 (19, 21, 22).
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However, these PCR assays were not optimized for maxi-
mum sensitivity or evaluated for specificity. Moreover, a
large number of individual PCR assays were required if
single primer sets were used on large numbers of clinical
specimens. To reduce the number of tests, we combined the
single PCR assays with a set of two multiplex PCR assays.
The tests were carried out in a 96-well microplate format,
allowing large-scale application, and were evaluated with
tonsillar specimens from pigs infected with S. suis strains.
The results showed that the multiplex PCR assays are spe-
cific and sensitive diagnostic tools suitable for the detection of
pigs carrying S. suis serotype 1 (and 14), 2 (and 1/2), 7, and 9
and virulent S. suis serotype 2 and highly virulent S. suis sero-
type 1 strains.
FIG. 1. PCR products obtained in multiplex PCR I (A) or multiplex PCR II (B) with purified chromosomal DNA (1 ng) of eight S. suis strains
spiked with 10 fg of pGL2-Basic vector. Samples were separated on a 2% agarose gel stained with ethidium bromide. Lane designations are
indicated. S. suis serotype 1/2, strain 5209 (lane 1); S. suis serotype 1, strain 5210 (lane 2); S. suis serotype 2 (EF*-positive), strain 5211 (lane 3);
S. suis serotype 7, strain 5216 (lane 4); S. suis serotype 9, strain 5218 (lane 5); S. suis serotype 14, strain 5223 (EF*-positive) (lane 6); S. suis type
1 (EF-positive), strain 6388 (lane 7); S. suis type 2 (EF-positive), strain 4005 (lane 8); negative control (without S. suis DNA) (lane 9); mixture of
chromosomal DNA (1 ng) of strains in lanes 1 to 8 (lane 10). Lane MW contains DNA molecular size markers (0.019 to 1.11 kbp; Roche); the
sizes (in base pairs) of the PCR products are indicated on the left.
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MATERIALS AND METHODS
Bacteria and growth conditions. Reference strains of S. suis serotypes 1/2 and
1 to 34 (5, 6, 8, 14), EF-positive strains of S. suis serotypes 1 (strain 6388) and 2
(strain 3), serotype 2 strains belonging to the five different EF* classes (20, 23,
27), 18 other streptococcal strains belonging to Lancefield groups A to E, G, L,
P, and Q, and 24 bacterial strains belonging to the genera Staphylococcus,
Micrococcus, Aerococcus, Actinobacillus, Bordetella, Escherichia, Pasteurella, Pro-
teus, Salmonella, and Serratia, and a yeast, a Cryptococcus sp. (collection ID-
Lelystad), were used in this study.
Strains were plated on Columbia blood agar plates (code CM 331; Oxoid Ltd.
Inc. Columbia, Md.) supplemented with 6% horse blood and grown overnight at
37°C in air with 5% CO2. Colonies were inoculated in Todd-Hewitt broth (code
CM 189; Oxoid) and grown overnight at 37°C.
Tonsillar specimens. Tonsils from 38 pigs obtained from 28 farms were col-
lected at the Animal Health Service, Boxtel, The Netherlands, and stored at
20°C. All pigs showed clinical signs of disease such as meningitis, sepsis,
pneumonia, or arthritis. S. suis strains were isolated from tissues typically af-
fected by S. suis such as brains, organs, lungs, or joints.
FIG. 2. Sensitivity of multiplex PCR I (A) and II (B) on a mixture of chromosomal DNAs of S. suis serotype 1, 7, and 9 (A) or on an EF-positive
S. suis serotype 2 strain (B). Samples were separated on a 2% agarose gel stained with ethidium bromide. The amount of target DNA tested in
the PCR assays is indicated above the lanes. All samples contained 10 fg of positive control DNA. Lane MW contains DNA molecular size markers;
the sizes (in base pairs) of the PCR products are indicated on the left.
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Tonsillar specimens were prepared for PCR by the multiscreen method as
described previously (28).
To evaluate the results obtained with the multiplex PCR assays, S. suis sero-
type 1 (and 14), 2 (and 1/2), 7, and 9 and EF-positive S. suis strains were directly
isolated from the tonsillar specimens with a bacteriological examination (28). To
do this, tonsillar specimens were plated, and colonies were lifted onto sterilized
GeneScreen Plus membranes (New England Nuclear Corp., Boston, Mass.) and
hybridized with serotype-specific cps probes or an epf-specific probe (see below).
Hybridizing colonies were subcultured, characterized and serotyped by standard
procedures (4, 26).
PCR conditions. Oligonucleotide primers used in the multiplex PCR assays for
the detection of S. suis serotype 1 (and 14), 2 (and 1/2), and 9 and EF-positive S.
suis strains were as described before (22, 28), except for the reverse primer in the
serotype 2-specific PCR. The new primer has the sequence 5-CATTTCCTAA
GTCTCGCACC-3 and corresponds to positions 14027 to 14008 in the cps2J
gene (22). The primers used for the detection of serotype 7 strains correspond to
positions 3185 to 3206 and 3726 to 3705 in the serotype 7-specific cps gene (21).
The sequences were 5-GAATCAATCCAGTCAGTGTTGG-3 and 5-CTAA
TTCGATACGAAGCTAAAC-3.
In multiplex PCR I, primers specific for serotype 1 (and 14), 7, and 9 strains
were combined. Amplified fragments are 441, 541, and 388 bp in length, respec-
tively. In multiplex PCR II, primers specific for serotype 2 and EF-positive strains
were combined. In this PCR, amplified fragments are 236 and 626 bp in length,
respectively.
To control for failure of DNA amplification and to confirm the reliability of
the PCR assays, each sample was spiked with a positive control template. For
this, the pGL2-Basic vector (Promega, Madison, Wis.) encoding the firefly lu-
ciferase gene (luc) was used. Oligonucleotide primers amplifying a part of the luc
gene, corresponding to positions 723 to 744 and 1672 to 1651 on the pGL2-Basic
vector, had the sequences 5-CGTCAGATTCTCGCATGCCAGA-3 and 5-T
TGCGTCGAGTTTTCCGGTAAG-3. This resulted in a PCR product of 949
bp.
As the template for PCR, we used 1 ng of purified chromosomal DNA (16)
from bacterial strains or 25 l of clinical sample prepared for PCR as described
above. The reaction mixtures (50 l) contained 10 mM Tris-HCl (pH 8.3), 2 mM
MgCl2, 50 mM KCl, 0.2 mM each of the four deoxynucleotide triphosphates, 0.4
M each of the primers, and 1.5 U of AmpliTaq Gold DNA polymerase (Perkin
Elmer Applied Biosystems, Roche Molecular Systems, Branchburg, N.J.).
PCR mixtures were overlaid with two drops of mineral oil. DNA amplification
was carried out in microplates (Thermowell H; Corning Costar, Cambridge,
Mass.) in a DNA thermal cycler (Omnigene; Hybaid, Teddington, Middlesex,
United Kingdom). The program used for multiplex PCR I consisted of incuba-
tion for 10 min at 95°C and 40 cycles of 0.45 min at 94.8°C, 1.10 min at 60°C, and
3 min at 72°C, followed by incubation for 10 min at 72°C. The program used for
multiplex PCR II consisted of incubation for 10 min at 95°C and 40 cycles of 0.45
min at 94.8°C, 1.10 min at 63°C, and 1.20 min at 72°C, followed by incubation for
10 min at 72°C. Then 20 l of the PCR products was separated by electrophoresis
on 2% agarose gels, stained with ethidium bromide (0.25 g/ml), and photo-
graphed under UV light.
Hybridization. Reference strains of S. suis serotypes 1, 2, 7, and 9 and strain
3 (EF-positive) were used in individual PCR assays to amplify serotype 1-, 2-, 7-,
and 9-specifc cps fragments and an epf-specific fragment, respectively. These
fragments were purified from the amplification products with a High Pure PCR
product purification kit (Roche) and labeled with [-32P]dCTP (3,000 Ci
mmol1; Amersham Corp., Arlington Heights, Ill.) by use of a random primed
labeling kit (Roche). The DNA on the blots was hybridized at 65°C with appro-
priate DNA probes, as recommended by the supplier of the GeneScreen Plus
membranes. After hybridization, the membranes were washed twice with a so-
lution of 40 mM sodium phosphate (pH 7.2)–1 mM EDTA–5% sodium dodecyl
sulfate for 30 min at 65°C and twice with a solution of 40 mM sodium phosphate
(pH 7.2)–1 mM EDTA–1% sodium dodecyl sulfate for 30 min at 65°C.
DNA sequence analysis. DNA sequences were determined on an ABI Prism
3700 DNA analyzer system (Perkin Elmer Applied Biosystems). Samples were
prepared by use of an ABI Prism BigDye terminator cycle sequencing ready
reaction kit (Perkin Elmer Applied Biosystems).
Statistical analysis. For each serotype, the association between clinical disease
and tonsillar carriership was assessed by Fisher’s exact test on independence in
2 by 2 tables. A P value smaller than 0.05 was considered significant. These tests
were carried out with StatXact 4 for Windows (Cytel Software Corporation,
Cambridge, Mass.).
RESULTS
Specificity of the multiplex PCR assays. To test the speci-
ficity of the multiplex PCR assays, PCRs were performed on
the various S. suis reference strains and on a panel of 18
streptococcal and 24 nonstreptococcal strains. As shown in Fig.
1A and B, PCR products of the predicted sizes were obtained
on chromosomal DNAs (1 ng) of the S. suis serotype 1/2, 1, 2,
7, 9, and 14 and EF-expressing strains. Multiplex PCR II am-
plified a fragment of about 2,400 bp of chromosomal DNA of
the S. suis serotype 14 strain (Fig. 1B, lane 6). This indicates
the presence of an S. suis strain expressing an EF* protein.
Multiple amplification products were observed in a mixture of
chromosomal DNA of the above-mentioned eight strains (Fig.
1A and B, lane 10). No amplification products were obtained
on any of the other S. suis serotypes or on any of the other
strains examined (results not shown). This indicates that the
multiplex PCR assays are highly specific for the detection of S.
suis serotype 1, 2, 1/2, 7, 9, and 14 and EF-positive S. suis
strains.
As expected, in the negative control (without chromosomal
S. suis DNA), an amplification product of the internal positive
control was detected (Fig. 1A and B, lane 9). No interference
was observed between the internal positive control primer set
with chromosomal DNA (1 ng) of the S. suis reference strains
and vice versa between the S. suis primer sets and internal
positive control DNA (1 ng) (results not shown).
We also used the multiplex PCR II on chromosomal DNA of
EF*-producing serotype 2 strains. In addition to the serotype
2-specific cps PCR products, epf* PCR products of various
sizes (1,278, 1,505, 2,313, 2,537, and 2,993 bp) were expected
(28). However, a faint amplification product was obtained on
chromosomal DNA of the strain expressing the smallest EF*
protein, whereas no amplification products could be detected
in the other EF*-producing strains (results not shown). Ap-
parently, multiplex PCR II is not able to efficiently detect
EF*-producing strains.
Sensitivity of the two multiplex PCR assays. The sensitiv-
ity of the multiplex PCR assays was determined with chro-
TABLE 1. Comparison of multiplex PCR assays and bacteriological
examination for 38 tonsillar specimens from diseased pigs
Multiplex
PCR
resulta
No. (%) of tonsillar specimens
PCR positive,
bacterial
exam
positive
PCR positive,
bacterial
exam
negative
PCR negative,
bacterial
exam
negative
PCR negative,
bacterial
exam
positive
Serotype 1
(or 14)
1b (3) 0 (0) 37 (97) 0 (0)
Serotype 2
(or 1/2)
12c (31) 6 (16) 20 (53) 0 (0)
EF positive 5 (13) 0 (0) 33 (87) 0 (0)
Serotype 7 14 (37) 3 (8) 21 (55) 0 (0)
Serotype 9 28 (74) 4 (10) 6 (16) 0 (0)
Total 60 (31) 13 (7) 117 (62) 0 (0)
a Similar PCR products were amplified for S. suis serotype 1 and 14 strains and
for serotype 2 and 1/2 strains due to common capsular genes (18).
b S. suis serotype 14 strain as detected by bacteriological examination.
c S. suis serotype 1/2 (7 of 12) and EF-positive S. suis serotype 2 strains (5 of
12) as detected by bacteriological examination.
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mosomal DNA of S. suis serotype 1, 2, 7, and 9 and an
EF-positive serotype 2 strain. In both multiplex PCR as-
says, 10 fg of chromosomal DNA of the various serotypes
and phenotypes was sufficient to amplify a fragment which
could easily be detected by eye on an agarose gel (Fig. 2A
and B).
Evaluation of the multiplex PCR assays. We subsequently
analyzed tonsillar specimens by multiplex PCR assays and by
bacteriological examination (28) to compare the two tests. The
results are summarized in Table 1, and several examples are
shown in Fig. 3A and B. All tonsillar specimens bacteriologi-
cally positive for a specific serotype or phenotype were also
positive in the corresponding PCR. Moreover, tonsils negative
in the multiplex PCR for a specific serotype or phenotype were
also negative for this particular serotype or phenotype with the
bacteriological method. Some samples positive in the multiplex
PCR tested bacteriologically negative (3 of 17 for serotype 7, 4
of 28 for serotype 9, and 6 of 18 for serotype 2 [and 1/2]). This
suggests that, especially for serotype 2 (and 1/2), the PCR
method is more sensitive than the bacteriological examination.
FIG. 3. PCR products in multiplex PCR I (A) and multiplex PCR II (B) obtained directly on tonsillar specimens collected from diseased pigs
carrying serotype 1 (and 14), 2 (and 1/2), 7, and 9 and EF-positive S. suis strains as detected by bacteriological examination. PCR products were
obtained from tonsillar specimens collected from pigs carrying S. suis serotype 1/2 (lane 1); S. suis serotype 7 (lane 2); S. suis serotype 9 (lane 3);
S. suis serotype 7 and 9 strains (lane 4); S. suis serotype 7 and 14 strains (lane 5); S. suis serotype 1/2 and 9 strains (lane 6); S. suis serotype 2
(EF-positive phenotype) and 7 strains (lane 7); S. suis serotype 2 (EF-positive phenotype) and 9 strains (lane 8); and S. suis serotype 1/2, 7, and
9 strains (lane 9). All samples contained 10 fg of positive control DNA. Lane MW contains DNA molecular size markers; the sizes (in base pairs)
of the PCR products are indicated on the left.
2926 WISSELINK ET AL. J. CLIN. MICROBIOL.
 at LAN
D
BO
UW
UNIVERSITEIT on O
ctober 2, 2008 
jcm.asm.org
D
ow
nloaded from
 
To corroborate this and to exclude false-positive PCR results,
we repeatedly tested the samples both by PCR and by bacte-
riological examination. The same results were obtained. More-
over, the specificity of the serotype 2 PCR product of samples,
which could not be confirmed bacteriologically, was further
examined by sequence analysis and cross-hybridization exper-
iments. All fragments showed the expected serotype 2-specific
sequence and hybridized specifically with the serotype 2-spe-
cific probe (data not shown). From these data, we conclude
that the multiplex PCR assays are more sensitive than the
bacteriological examination.
Comparison of serotypes isolated from tonsils and affected
tissues of diseased pigs. We next compared the results of the
serotypes found by PCR in tonsillar specimens of diseased pigs
and the serotypes of the strains isolated from the affected
tissues of the same pigs. Table 2 shows that in 89% (34 of 38)
of the cases, an S. suis strain in the tonsils belonged to the same
serotype as the disease-causing strain. For some serotypes, a
significant (P  0.05) association between clinical illness and
carrier state could be found. Four of five pigs carrying EF-
positive S. suis serotype 2 strains and most of the pigs (27 of 32)
carrying a serotype 9 strain were also clinically ill due to such
a strain. Such an association was not found in EF-negative
serotype 2 (and 1/2) and 7 strains. One and two pigs suffered
from serotype 1/2 and 7 infections, respectively, whereas 13
and 17 pigs, respectively, carried these bacteria on their tonsils.
This could indicate that compared to the EF-positive serotype
2 and serotype 9 strains, EF-negative serotype 2 (and 1/2) and
7 strains are less virulent.
Multiple serotypes in tonsillar specimens from pigs. In 66%
(25 of 38) of the tonsillar specimens examined, two or more S.
suis strains were identified by the multiplex PCR assays on the
same tonsillar specimen (Table 3). Most frequently, a combi-
nation of serotypes 9 and 2 (and 1/2) (18%) and serotypes 9
and 7 (16%) strains were detected by the multiplex PCR as-
says. In five (13%) of the tonsillar samples, the multiplex PCR
assays identified S. suis strains belonging to three different
serotypes, serotypes 2 (and 1/2), 7, and 9.
DISCUSSION
We previously showed that a PCR based on the epf gene
specifically detects virulent strains of S. suis serotype 2 and
highly virulent strains of S. suis serotype 1 (28). In addition,
PCR assays on the serotype-specific cps genes of S. suis sero-
types 1, 2, 7, and 9 specifically identified S. suis serotype 1 (and
14), 2 (and 1/2), 7, and 9 strains (21, 22). In the present study,
we improved the diagnostic value of these PCR methods by a
multiplex approach. In two separate reactions, we could easily
identify serotype 1 (and 14), 7, and 9 (multiplex PCR I) as well
as serotype 2 (and 1/2) and EF-positive S. suis strains (multi-
plex PCR II). The multiplex PCR assays are easy to perform
and allow large-scale application; 96 samples can be processed
simultaneously. Compared to standard bacteriological assays,
the PCR assays are much more rapid to perform. Therefore,
these assays may be important diagnostic tools to detect pigs
carrying the most frequently isolated serotypes and virulence-
associated phenotypes of S. suis. It may be applicable for ep-
idemiological and transmission studies and can contribute to
efforts to control or eradicate S. suis infections.
Evaluation of the multiplex PCR assays with tonsillar spec-
imens from diseased pigs showed that both assays are highly
specific and sensitive. The bacteriological examination con-
firmed most (94%) of the results obtained with the multiplex
PCR assays. The PCR method seemed to be more sensitive
than the bacteriological method, since 13 of 73 samples posi-
tive by PCR were negative by bacteriological examination. Low
levels of bacterial cells (live or dead) in the tonsillar specimens
may explain the differences in results obtained with the two
methods. S. suis strains producing an EF* protein yielded in
multiplex PCR II only the serotype 2 products, although larger
epf* PCR products of various sizes were also expected (28).
Apparently, in the multiplex PCR, the epf* gene was far less
efficiently amplified than the 236-bp amplicon of the serotype
2-specific cps gene. Since the frequency of S. suis strains iso-
lated from diseased pigs which produce the EF* protein is very
low (29), detecting strains producing an EF* protein in the
multiplex PCR is a not a necessity.
In the bacteriological examination, we isolated serotype 1/2
TABLE 2. S. suis strains isolated from affected tissues compared
with S. suis strains detected by multiplex PCR assays on tonsils from
38 diseased pigs
S. suis strain
No. of pigs in which bacteria were:
Isolated from
affected
tissues
Detected by
PCR on
tonsils
Isolated from
affected
tissues and
detected by
PCR on
tonsils
Serotype 1 (or 14) 1 0 0
Serotype 2 (or 1/2)a 1 13 1
EF positive 4 5 4
Serotype 7 2 17 2
Serotype 9a 29 32 27
NTb 1 0 0
Total 38 61 34
a Significant association between clinical disease and tonsillar carriership.
b NT, nontypeable.
TABLE 3. Multiple serotypes of S. suis strains in tonsillar
specimens from diseased pigs as detected by multiplex PCR assays
No. of
S. suis
strains on
tonsillar
specimens
No. (%)
of
specimens
S. suis strain(s) detecteda
Serotype
1
(or 14)
Serotype
2
(or 1/2)
EF
positive
Serotype
7
Serotype
9
1 11 (29)     
1 (3)     
1 (3)     
2 7 (18)     
6 (16)     
3 (8)  * *  
2 (5)  * *  
1 (3)     
1 (3)     
3 5 (13)     
a S. suis serotype 1 (and 14), 7, and 9 strains were detected by multiplex PCR
I, and S. suis serotype 2 (and 1/2) and EF-positive S. suis strains were detected
by multiplex PCR II. , negative result; , positive result; *, tonsillar specimens
which contained an EF-positive serotype 2 strain.
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and 14 strains which hybridized specifically with the serotype 2
and 1 probes, respectively. In early studies it was shown that
serotype 1/2 strains cross-react in agglutination tests with an-
tiserum against serotype 1 and serotype 2 strains (13). For
serotype 1 and 14 strains, a one-way capsular cross-reaction in
agglutination tests was described (6).
A significant association between carriership and clinical
illness was observed for S. suis serotype 9 and EF-positive
strains and not for serotype 7 and EF-negative serotype 2 (or
1/2) strains. This could indicate that, compared to serotype 9
and EF-positive strains, serotype 7 and EF-negative serotype 2
(or 1/2) strains are less virulent. This idea corresponds well
with the observation that in The Netherlands, serotype 9 and
EF-positive strains were more frequently isolated from dis-
eased pigs than serotype 7 and EF-negative serotype 2 (or 1/2)
strains (29). Moreover, our data confirmed earlier studies in-
dicating that EF-negative serotype 2 and 1/2 strains are possi-
bly less or nonvirulent for pigs compared to EF-positive sero-
type 2 strains (27, 29). A role for EF in the virulence of S. suis
serotype 7 strains is not very likely because it was found in
recent studies that all serotype 7 strains isolated from diseased
pigs were EF-negative (1, 29). Whether the serotype 7 strains
detected by the multiplex PCR assays in this study are less
virulent than serotype 9 or EF-positive serotype 2 strains or
whether these strains are totally nonvirulent is unknown. Ex-
perimental infections in pigs will be necessary to examine the
virulence of the serotype 7 strains.
So far, the multiplex PCR assays have been carried out on
specimens consisting of tonsillar specimens from pigs. How-
ever, for routine detection of carriers, tonsillar swab specimens
from live animals would be preferred as a sampling method.
Our experience is that the PCR assay is applicable to tonsillar
swab specimens from live pigs, perhaps with a slightly lower
sensitivity (24). Nevertheless, additional experiments in which
carrier rates obtained on whole tonsils are compared with
those on tonsillar swabs and tonsillar biopsies are necessary.
Multiple S. suis serotypes were found on tonsils of diseased
pigs. Earlier, it was found that pigs can be infected with mul-
tiple serotypes of S. suis (15, 17). These findings may account
in part for the difficulty in disease control by vaccines. At
present, for control of the disease by vaccines, autogenous
bacterins are used. It seemed that these vaccines confer pro-
tection only against challenge with strains of a homologous
serotype (10). It can be hypothesized that a bacterin vaccine
prepared from one serotype may suppress clinical disease
caused by that particular serotype, but that new outbreaks
caused by S. suis strains belonging to other serotypes may
occur. Therefore, identification of specific strains, not only
those involved in clinical disease in infected herds but also
those involved in the carrier state, may be needed to provide
adequate control measures. The current multiplex PCR assays
can contribute to such an approach.
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